IMUX Award Disclosure
Nagel Robert Thorvald · SEC Form 4 · Filed Sep 18, 2026
Award
Calculated transaction value
$0
Nagel Robert Thorvald Director
IMUX
Immunic
IMUX
Transaction date
Sep 16, 2026
Public filing date
Sep 19, 2026
Filing lag
Filed 3 days later
IMUX daily price context
Close on/before transaction
$10.12
Sep 16, 2026
Close before public filing
$10.63
Sep 18, 2026
Return since public filing
0.0%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 25,370 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193805-26-001256
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Immunic, Inc. IMUX Current | Award | Sep 16, 2026 | $0 |